Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

Erstveröffentlichung

2014

Authors

Döhner, Hartmut

Luebbert, Michael

Fiedler, Walter

Fouillard, Loic

Haaland, Alf

et al.

Wissenschaftlicher Artikel

Published in

Blood ; 124 (2014), 9. - S. 1426-1433. - ISSN 0006-4971. - eISSN 1528-0020

Link to publication

https://dx.doi.org/10.1182/blood-2014-03-560557

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: acute myeloid-leukemia | polo-like kinase | inhibits tumor-growth | advanced solid tumors | antitumor-activity | elderly-patients | cancer-therapy | older patients | open-label | selective inhibitor
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record